YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novo Nordisk launches GLP-1 pill for obesity in US

Posted online

Novo Nordisk is rolling out a GLP-1 pill in the United States that's specifically made for weight loss.

The Wegovy pill ranges from $149 to $299 per month.

U.S. regulators cleared the treatment for obesity about two weeks ago.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Startup offers contracted on-site childcare for businesses

Company Nanny owner prepares to launch concept in Springfield.

Most Read
SBJ.net Poll
Update cookies preferences